Asbjørn Hróbjartsson: h-index, Total Citations, and Citation Map
Asbjørn Hróbjartsson's h-index is 76 (139 i10-index, 268,511+ total citations across 3+ publications) according to Google Scholar as of May 2026. Asbjørn Hróbjartsson is affiliated with Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark.
Asbjørn Hróbjartsson is a researcher affiliated with Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, specializing in clinical epidemiology, evidence-based medicine, bias. Their work has been cited 268,511 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Asbjørn Hróbjartsson's Citation Metrics
Bibliometric impact based on 3 indexed publications.
- H-Index
- 76
- i10-Index
- 139
- Total Citations
- 268,511
- Citing Countries
- 31
As of May 2026.
Asbjørn Hróbjartsson has an h-index of 76 and 268,511 total citations across 3 publications, with research cited by institutions in 31 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Asbjørn Hróbjartsson's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 268,511 citations for Asbjørn Hróbjartsson
We've shown the most-cited 5,000. Unlock the full crawl (268,496 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021149,816
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
2 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher developed ROBINS-I, a seminal tool for assessing risk of bias in non-randomised studies of interventions, published in the BMJ.
The researcher developed RoB 2, a revised tool for assessing risk of bias in randomised trials, establishing a widely adopted standard for methodological rigor in clinical research.
The researcher established the PRISMA 2020 statement, a widely adopted updated guideline for reporting systematic reviews that has significantly standardized methodological transparency in medical and scientific literature.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
